The Effect of Perinatal Gadolinium-Based Contrast Agents on Adult Mice Behavior

Written By Bridget Belo

Article Abstract Link: https://pubmed.ncbi.nlm.nih.gov/28915162/

Journal: Investigative Radiology

Authors and Affiliations: Khairinisa, Miski Aghnia MBiomedSc*†; Takatsuru, Yusuke MD*; Amano, Izuki MD*; Erdene, Khongorzul MD‡; Nakajima, Takahito MD‡; Kameo, Satomi PhD§; Koyama, Hiroshi MD§; Tsushima, Yoshito MD‡∥; Koibuchi, Noriyuki MD, PhD*

From the *Department of Integrative Physiology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan; †Department of Pharmacology and Clinical Pharmacy, Universitas Padjadjaran, Bandung, Indonesia; Departments of ‡Diagnostic Radiology and Nuclear Medicine, and §Public Health, Gunma University Graduate School of Medicine; and ∥Research Program for Diagnostic and Molecular Imaging, Division of Integrate

Bridget Belo
Previous

Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents (Mar 2018).
Next

Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus (October 2017).